These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8182127)

  • 21. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.
    Weitzmann MN; Roggia C; Toraldo G; Weitzmann L; Pacifici R
    J Clin Invest; 2002 Dec; 110(11):1643-50. PubMed ID: 12464669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
    Thouverey C; Caverzasio J
    Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human recombinant interleukin-1 receptor antagonist blocks bone resorption induced by interleukin-1 beta but not interleukin-1 alpha.
    Chole RA; Tinling SP; Faddis BT
    Calcif Tissue Int; 1994 Jul; 55(1):12-5. PubMed ID: 7922783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.
    Abrahamsen B; Bendtzen K; Beck-Nielsen H
    Bone; 1997 Mar; 20(3):251-8. PubMed ID: 9071476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.
    Passeri G; Girasole G; Jilka RL; Manolagas SC
    Endocrinology; 1993 Aug; 133(2):822-8. PubMed ID: 8393776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy.
    Pacifici R; Vannice JL; Rifas L; Kimble RB
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1135-41. PubMed ID: 8077304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of physiological dosage of estrogen on the prevention of bone loss in rats induced by ovariectomy].
    Gao X; Xue Y; Zheng M
    Wei Sheng Yan Jiu; 1999 Jul; 28(4):227-9. PubMed ID: 11938983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
    Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
    Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
    Rogers A; Clowes JA; Pereda CA; Eastell R
    Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
    Abrahamsen B; Bonnevie-Nielsen V; Ebbesen EN; Gram J; Beck-Nielsen H
    J Bone Miner Res; 2000 Aug; 15(8):1545-54. PubMed ID: 10934653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panax notoginseng saponins mitigate ovariectomy-induced bone loss and inhibit marrow adiposity in rats.
    Fan JZ; Wang Y; Meng Y; Li GW; Chang SX; Nian H; Liang YJ
    Menopause; 2015 Dec; 22(12):1343-50. PubMed ID: 26035148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease.
    Holmlund A; Hänström L; Lerner UH
    J Clin Periodontol; 2004 Jun; 31(6):475-82. PubMed ID: 15142219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.